NEUE (NeueHealth) ROE % Adjusted to Book Value: 0.00% (As of Jun. 2025)


NEUE NeueHealth Inc NEUE
20 GF Score
Price $6.75
GF Value $8.81
! 6 Warning Signs
View Full Analysis

What is NeueHealth ROE % Adjusted to Book Value?

NeueHealth NEUE 20 ROE % Adjusted to Book Value is 0.00% as of Jun. 2025. GuruFocus rates NEUE with a GF Score™ of 20/100 and a GF Value™ of $8.81. The stock has 6 warning signs investors should review.

NeueHealth's ROE % for the quarter that ended in Jun. 2025 was 0.00%. NeueHealth's PB Ratio for the quarter that ended in Jun. 2025 was N/A. NeueHealth's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2025 was N/A.

NeueHealth ROE % Adjusted to Book Value Related Terms

NeueHealth ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for NeueHealth's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeueHealth ROE % Adjusted to Book Value Chart

NeueHealth Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 0.00 -195.47 0.00 0.00 0.00

NeueHealth Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NEUE vs PFHO, UNH, CVS: ROE % Adjusted to Book Value Comparison

For the Healthcare Plans subindustry, NeueHealth's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeueHealth ROE % Adjusted to Book Value vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, NeueHealth's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where NeueHealth's ROE % Adjusted to Book Value falls into.


NEUE
20GF Score
NeueHealth Inc NEUE
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeueHealth ROE % Adjusted to Book Value Calculation

NeueHealth's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

NeueHealth's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
NeueHealth (NEUE) has a ROE % Adjusted to Book Value of 0.00% as of Jun. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on NeueHealth and its competitors.
Is NeueHealth's ROE % Adjusted to Book Value too high?
NeueHealth's current ROE % Adjusted to Book Value is 0.00%. Overall, NeueHealth has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does NeueHealth's ROE % Adjusted to Book Value compare to PFHO and UNH?
NeueHealth's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Plans company?
A good ROE % Adjusted to Book Value depends on the Healthcare Plans industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on NeueHealth and its competitors. NeueHealth's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeueHealth stock overvalued right now?
NeueHealth (NEUE) has a current ROE % Adjusted to Book Value of 0.00%. The stock's GF Value™ is $8.81, compared to a current price of $6.75 — trading 23.3% below its estimated fair value. The current ROE % Adjusted to Book Value is 0.00%. NeueHealth's overall GF Score™ is 20/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For NeueHealth (NEUE), the current ROE % Adjusted to Book Value is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NeueHealth (NEUE) Overvalued in 2026?

Based on GuruFocus' analysis, NeueHealth stock appears to be undervalued. The current stock price of $6.75 is trading 23.3% below its estimated GF Value™ of $8.81.

Key valuation signals for NEUE:

  • ROE % Adjusted to Book Value: 0.00%
  • GF Value™: $8.81 vs. price of $6.75 (23.3% below fair value)
  • GF Score™: 20/100 with 6 warning signs

No single metric tells the full story. See the NEUE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NeueHealth Business Description

Address 9250 NW 36th Street, Suite 420, Doral, FL, USA, 33178
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
20GF Score

Get the complete analysis for NEUE

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.75
Price
$8.81
GF Value